Aspirin use is associated with lower prostate cancer risk in male carriers of BRCA mutations.

Abstract excerpt

Previous studies have shown that male BRCA mutation carriers stand at increased risk of developing prostate cancer and have concerns about developing cancer. Genetic counseling practitioners often discuss strategies for reducing the risk of cancer for patients at high risk due to their genetic background. Addressing modifiable health habits is one such strategy. Unfortunately, modifiable risk factors for prostate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Aspirin
• Share to Genes, BRCA1
• Share to Genes, BRCA2